Chinese contract development and manufacturing organisation (CDMO) Healsun Biopharm has raised nearly 250 million yuan ($36.7 million) in a Series B round. Separately, Warburg Pincus and Macquarie Asset Management are reportedly close to making an investment of about $450 million in China’s Bohao Internet Data Services.
Healsun raises nearly $37m in Series B
Chinese contract development and manufacturing organisation (CDMO) Healsun Biopharm has raised nearly 250 million yuan ($36.7 million) in a Series B round of financing led by the 10 billion-yuan ($1.5 billion) Shanghai Biomedical Industry Equity Investment Fund.
